Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianhe Nuoya Bio-engineering is a biotechnology company based in Guangzhou, China, specializing in the collection, processing, and storage of umbilical cord blood stem cells. The company operates the Guangdong Cord Blood Bank, which is one of the few officially licensed cord blood banking facilities in the People's Republic of China. As a key subsidiary of Global Cord Blood Corporation, it provides essential services for families seeking to preserve stem cells for potential future medical use. The stored stem cells are used in the treatment of various hematological and immunological disorders, including leukemia and thalassemia. The company maintains state-of-the-art laboratories and cryopreservation facilities to ensure the viability and safety of the biological samples. Its operations are a critical component of the regional healthcare infrastructure in Southern China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Municipality Tianhe Nuoya Bio-engineering.